1. 23% of Bristol Myers-Squibb Shareholders Back Proposal About Drug Pricing, Compensation

    23% of Bristol Myers-Squibb Shareholders Back Proposal About Drug Pricing, Compensation

    "Our resolution asked how these very real concerns are being incorporated into corporate governance policies on executive compensation and, importantly, if these policies and practices are consistent with our company's stated mission of 'providing access to prescription medicines at fair prices,'" said ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned

  3. Authors